CLDN5 and myeloid sarcoma: In EAE, as in human MS, there are selective alterations in TJ proteins, including a notable loss of claudin-3, while other key TJs such as ZO-1, occludin, and claudin-5 are also significantly disrupted, contributing to barrier breakdown and neuroinflammation [135, 136].